Smart delivery for superior treatment.

For patients, worldwide.

As a bio-pharmaceutical company, AMW provides patients with biodegradable drug delivery systems for value-added and cost-effective therapies. With state-of-the-art production facilities in Germany, the entire pharmaceutical value chain is covered. Our employees, with their individual ideas and skills, are crucial to our success.

Our focus

Research & Development

Cutting-edge technology and know-how in extrusion: AMW’s technology platform as the basis for our growing development pipeline of drug delivery systems

Products

Our implants goserelin and leuprorelin for the treatment of hormone-sensitive tumors

Services

We support our pharma and biotech partners locally and globally – from technology collaboration to contract development

We cover the entire value chain for drug delivery systems – from (co-)development and manufacturing to commercialization or out-licensing.

Careers at AMW

Pharmaceutical worker (m/f/d) in shift operation
Junior Controller (m/f/d)

Latest News

AMW Further Strengthens Executive Leadership Team by Appointing Dr. Joerg Serafimov as Chief Business Officer

Warngau, Germany, January 9, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that Dr. Joerg Serafimov has been appointed to the newly created role as Chief Business Officer (CBO), effective January 1, 2024. In this capacity, he is responsible for International Business and Licensing, Key Account Management, […]

read more

AMW strengthens management team with the appointment of Dr. Joerg Serafimov as Chief Business Officer

Warngau, January 9, 2024 AMW GmbH, a bio-pharmaceutical company specializing in innovative drug delivery systems, today announced that Dr. Joerg Serafimov has been appointed Chief Business Officer (CBO) effective January 1, 2024. In this newly created position, he is responsible for International Business and Licensing, Key Account Management, Business Development, Regulatory Affairs, Marketing and Public […]

read more

AMW Expands Leadership Team for Strategic Expansion

Warngau, Germany, November 28, 2023 AMW GmbH, a specialty pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the expansion of its leadership team to implement its strategic growth strategy. Following Philipp Karbach taking over the role of Chief Executive Officer (CEO) in June this year, Sebastian Herzog now strengthens the management team […]

read more